Abstract
Patients with suspected malignancy, infection, inflammation, trauma, or metabolic bone disease are referred for bone scintigraphy to establish the extent, if any, of skeletal involvement. Often, extra-osseous uptake of radiotracer is identified, which may either be an incidental finding or relevant to the underlying bone pathology.
While identification of urinary tract abnormalities due to the renal excretion of 99mTc-phosphates through the kidneys and bladder is not uncommon, uptake of tracer in other body systems is more unusual and may provide clues as to the underlying diagnoses. It is therefore of important not to overlook the soft tissues when reporting bone scans.
In this chapter, we describe the imaging appearances of extra-osseous 99mTc-diphosphonate uptake in the head, neck, thorax, abdomen, and muscle. The pathophysiological mechanisms that account for soft tissue deposition, technical pitfalls, and artifacts that can compromise bone scintigraphic acquisition and its subsequent analysis are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams KJ, Shuler SE, Witherspoon LR, Neely HR (1980) A retrospective analysis of renal abnormalities detected on bone scans. Clin Nucl Med 5:1–7
Ahmad M, Dubiel JP, Verdon TA, Martin RH (1976) Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm. Circulation 53:833–838
Akmal M, Goldstein DA, Telfer N, Wilkinson E, Massry SG (1978) Resolution of muscle calcification in rhabdomyolysis and acute renal failure. Ann Intern Med 89:928–930
Ali A, Turner DA, Rosenbush SW, Fordham EW (1981) Bone scintigram in cardiac amyloidosis: a case report. Clin Nucl Med 6:105–108
Arbona GL, Antonmattei S, Tetalman MR, Scheu JD (1980) Tc-99m-diphosphonate distribution in a patient with hypercalcemia and metastatic calcifications. Clin Nucl Med 5:422
Atkins HL, Oster ZH (1984) Myocardial uptake of a bone tracer associated with hypercalcemia. Clin Nucl Med 9:613–615
Baumert JE, Lantieri RL, Horning S, McDougall IR (1980) Liver metastases of breast carcinoma detected on 99mTc-methylene diphosphonate bone scan. AJR Am J Roentgenol 134:389–391
Berg GR, Kalisher L, Osmond JD, Pendergrass HP, Potsaid MS (1973) 99mTc-diphosphonate concentration in primary breast carcinoma. Radiology 109:393–394
Billinghurst MW, Rempel S, Westendorf BA (1979) Radiation decomposition of technetium-99m radiopharmaceuticals. J Nucl Med 20:138–143
Bonte FJ, Parkey RW, Graham KD, Moore J, Stokely EM (1974) A new method for radionuclide imaging of myocardial infarcts. Radiology 110:473–474
Bossuyt A, Verbeelen D, Jonckheer MH, Six R (1979) Usefulness of 99mTc-methylene diphosphonate scintigraphy in nephrocalcinosis. Clin Nucl Med 4:333–334
Braun SD, Lisbona R, Novales-Diaz JA, Sniderman A (1979) Myocardial uptake of 99mTc-phosphate tracer in amyloidosis. Clin Nucl Med 4:244–245
Brill DR (1977) Gynecomastia demonstrated on the bone scan. J Urol 118:62–63
Brill DR (1981) Radionuclide imaging of nonneoplastic soft tissue disorders. Semin Nucl Med 11:277–288
Buja LM, Tofe AJ, Kulkarni PV et al (1977) Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. J Clin Invest 60:724–740
Burnett KR, Lyons KP, Brown WT (1984) Uptake of osteotropic radionuclides in the breast. Semin Nucl Med 14:48–49
Buxton-Thomas MS, Wraight EP (1983) High renal activity on bone scintigrams. A sign of hypercalcaemia? Br J Radiol 56:911–914
Byun HH, Rodman SG, Chung KE (1976) Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J Nucl Med 17:374–375
Carlson DH, Simon H, Wegner W (1977) Bone scanning and diagnosis of reflex sympathetic dystrophy secondary to herniated lumbar disks. Neurology 27:791–793
Charkes ND (1979) Mechanisms of skeletal tracer uptake. J Nucl Med 20:794–795
Chaudhuri TK (1976a) Liver uptake of 99mTc-diphosphonate. Radiology 119:485–486
Chaudhuri TK (1976b) The effect of aluminum and pH on altered body distribution of 99mTc-EHDP. Int J Nucl Med Biol 3:37
Chaudhuri TK, Gulesserian HP, Christie JH, Tonami N (1974) Extraosseous noncalcified soft-tissue uptake of 99mTc-polyphosphate. J Nucl Med 15:1054–1056
Choy D, Murray IP, Hoschl R (1981) The effect of iron on the biodistribution of bone scanning agents in humans. Radiology 140:197–202
Cohenpour M, Simon YC, Zenaty I, Horne T (2002) Unusual urinary bladder accumulation in bone scan. Semin Nucl Med 32:231–232
Conger JD, Hammond WS, Alfrey AC, Contiguglia SR, Stanford RE, Huffer WE (1975) Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med 83:330–336
Cornelius EA (1982) Nuclear medicine imaging in rhabdomyolysis. Clin Nucl Med 7:462–464
Costello P, Gramm HF, Steinberg D (1977) Simultaneous occurrence of functional asplenia and splenic accumulation of diphosphonate in metastatic breast carcinoma. J Nucl Med 18:1237–1238
Crawford JA, Gumerman LW (1978) Alteration of body distribution of 99mTc-pyro phosphate by radiographic contrast material. Clin Nucl Med 3:305–307
de Graaf P, Pauwels EK, Schicht IM, Feitsma RI, de Graeff J (1979) Scintigraphic detection of gastric calcification in dialysis patients. Diagn Imaging 48:171–176
Edeling CJ (1983) 99mTc-methylene diphosphonate uptake in a primary Wilms’ tumor. Eur J Nucl Med 8:30
Fink-Bennett D, Dworkin H (1977) Incidental detection of a horseshoe kidney on radionuclide bone images. Radiology 123:392
Floyd JL, Prather JL (1977) 99mTc-EHDP uptake in ischemic muscle. Clin Nucl Med 2:281–282
Garcia AC, Yeh SDJ, Benua RS (1977) Accumulation of bone-seeking radionuclides in liver metastasis from colon carcinoma. Clin Nucl Med 2:265–269
Garland DE, Blum CE, Waters RL (1980) Periarticular heterotopic ossification in head-injured adults. Incidence and location. J Bone Joint Surg Am 62:1143–1146
Gentili A, Miron SD, Bellon EM (1990) Nonosseous accumulation of bone-seeking radiopharmaceuticals. Radiographics 10:871–881
Gerhold JP, Klingensmith WCI, Loeffel SC (1980) Focal uptake of Tc-99m-MDP in renal metastases from squamous cell carcinoma of the lung. Clin Nucl Med 5:522
Gnanasegaran G, Cook G, Adamson K, Fogelman I (2009) Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med 39:380–395
Go RT, Doty BD, Chiu CL, Christie JH (1975) A new method of diagnosing myocardial contusion in man by radionuclide imaging. Radiology 116:107–110
Goldfarb CR, Shah PJ, Jay M (1979) Extraosseous uptake of bone-seeking tracers: an expected but unsuspected addition to the list. Clin Nucl Med 4:194–195
Goy W, Crowe WJ (1976) Splenic accumulation of 99mTc-diphosphonate in a patient with sickle cell disease: case report. J Nucl Med 17:108–109
Grames GM, Jansen C, Carlsen EN, Davidson TR (1975) The abnormal bone scan in intracranial lesions. Radiology 115:129–134
Gray HW (1987) Soft tissue uptake of bone agents. In: Fogelman I (ed) Bone scanning in clinical practice. Springer, London/Berlin
Guiberteau MJ, Potsaid MS, McKusick KA (1976) Accumulation of 99mTc-diphosphonate in four patients with hepatic neoplasm: case reports. J Nucl Med 17:1060–1061
Harbert JC (1976) Letter: focal renal activity in bone scans. J Nucl Med 17:426–427
Hardy JG, Anderson GS, Newble GM (1976) Uptake of 99mTc-pyrophosphate by metastatic extragenital seminoma. J Nucl Med 17:1105–1106
Harwood SJ (1978) Splenic visualization using 99mTc-methylene diphosphonate in a patient with sickle cell disease. Clin Nucl Med 3:308–309
Haseman MK (1983) Accumulation of a bone imaging agent in liver metastases from prostate carcinoma. Clin Nucl Med 8:488–489
Hassan et al. (2012) Heterotrophic ossification in a patient suspected of having osteomyelitis: additional value of SPECT/CT. Clin Nucl Med 37(2):170–1
Hattner RS, Miller SW, Schimmel D (1975) Significance of renewal asymmetry in bone scans: experience in 795 cases. J Nucl Med 16:161–163
Hojelse C, Kristensen K, Sampson CB (1994) Factors which affect the integrity of radiopharmaceuticals. In: Sampson CB (ed) Textbook of radiopharmacy: theory and practice, 2nd edn. Gordon and Breach Publishers, New York
Howman-Giles RB, Gilday DL, Ash JM, Brown RG (1978) Splenic accumulation of Tc-99m diphosphonate in thalassemia major. J Nucl Med 19:976–977
Howman-Giles RB, Gilday DL, Ash JM (1979) Radionuclide skeletal survey in neuroblastoma. Radiology 131:497–502
Ibis E, Krasnow ZA, Isitman AT, Akansel G, Erbay G, Collier BD (1992) Liver uptake of technetium-99m-labeled phosphate compounds: an updated gamut, 1992. Semin Nucl Med 22:202–205
Jengo JA, Mena I, Joe SH, Criley JM (1977) The significance of calcific valvular heart disease in Tc-99m pyrophosphate myocardial infarction scanning: radiographic, scintigraphic, and pathological correlation. J Nucl Med 18:776–780
Kim EE, Domstad PA, Choy YC, DeLand FH (1980) Accumulation of Tx-99m phosphonate complexes in metastatic lesions from colon and lung carcinomas. Eur J Nucl Med 5:299–301
Kozin F, Soin JS, Ryan LM, Carrera GF, Wortmann RL (1981) Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology 138:437–443
Kula RW, Engel WK, Line BR (1977) Scanning for soft-tissue amyloid. Lancet 1:92–93
Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS (1983) Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology 148:239–242
Lieberman CM, Hemingway DL (1979) Splenic visualization in a patient with glucose-6-phosphate dehydrogenase deficiency. Clin Nucl Med 4:405–406
Lin DS (1988) Uniappendicular increased uptake in bone imaging. Semin Nucl Med 18:165–166
Lowenthal IS, Tow DE, Chang YC (1975) Accumulation of 99mTc-polyphosphate in two squamous cell carcinomas of the lung: case report. J Nucl Med 16:1021–1023
Lutrin CL, McDougall IR, Goris ML (1978) Intense concentration of technetium-99m pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease. Radiology 128:165–167
Maher FT (1975) Evaluation of renal and urinary tract abnormalities noted on scintiscans: a retrospective study of 1,711 radioisotope skeletal surveys performed in an 18-month period. Mayo Clin Proc 50:370–378
Manoli RS, Soin JS (1978) Unilateral increased radioactivity in the lower extremities on routine 99mTc-pyrophosphate bone imaging. Clin Nucl Med 3:374–378
McCartney W, Nusynowitz ML, Reimann BE, Prather J, Mazat B (1976) 99MTc-diphosphonate uptake in neuroblastoma. AJR Am J Roentgenol 126:1077–1081
McDougall IR, Pistenma DA (1974) Concentration of 99mTc diphosphonate in breast tissue. Radiology 112:655–657
McLaughlin AF (1975) Uptake of 99mTc bone-scanning agent by lungs with metastatic calcification. J Nucl Med 16:322–323
McRae J, Hambright P, Valk P, Bearden AJ (1976) Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution. J Nucl Med 17:208–211
Muheim G, Donath A, Rossier AB (1973) Serial scintigrams in the course of ectopic bone formation in paraplegic patients. Am J Roentgenol Radium Ther Nucl Med 118:865–869
Neely HR, Witherspoon LR, Shuler SE (1984) Genitourinary findings incidental to bone imaging. In: Silberstein EB (ed) Bone scintigraphy. Futura Pub. Co., Mount Kisco
Nisbet AP, Maisey MN (1982) Splenic accumulation of technetium 99m-methylene diphosphonate. Br J Radiol 55:454–455
Nordin BEC (1984) Metabolic bone and stone disease, 2nd edn. Churchill Livingstone, Edinburgh/New York
O’Connell ME, Sutton H (1976) Excretion of radioactivity in breast milk following 99Tcm-Sn polyphosphate. Br J Radiol 49:377–379
Oren VO, Uszler JM (1978) Liver metastases of oat cell carcinoma of lung detected on 99mTc-diphosphonate bone scan. Clin Nucl Med 3:355–358
Ozarda AT, Haynie TP, Gutierrez CR (1983) Recurrent renal cell carcinoma following nephrectomy mimicking a normal kidney on bone scan. Eur J Nucl Med 8:148–149
Parker JA, Jones AG, Davis MA, Mcilmoyle G, Tow DE (1976) Reduced uptake of bone-seeking radiopharmaceuticals related to iron excess. Clin Nucl Med 1:267–268
Planchon CA, Donadieu AM, Perez R, Cousins JL Jr (1983) Calcium heparinate induced extraosseous uptake in bone scanning. Eur J Nucl Med 8:113–117
Ponto JA, Swanson DP, Freitas JE (1987) Clinical manifestations of radiopharmaceutical formulation problems. In: Hladik WB, Saha GB, Study KT (eds) Essentials of nuclear medicine science. Williams & Wilkins, Baltimore/London
Prasquier R, Taradash MR, Botvinick EH, Shames DM, Parmley WW (1977) The specificity of the diffuse pattern of cardiac uptake in myocardial infarction imaging with technetium-99m stannous pyrophosphate. Circulation 55:61–66
Que L, Wiseman J, Hales IB (1980) Small cell carcinoma of the lung: primary site and hepatic metastases both detected on Tc-99m-pyrophosphate bone scan. Clin Nucl Med 5:260–262
Richards AG (1975) Letter: metastatic calcification and bone scanning. J Nucl Med 16:1087
Richman LS, Gumerman LW, Levine G, Sartiano GP, Boggs SS (1975) Localization of Tc99m polyphosphate in soft tissue malignancies. Am J Roentgenol Radium Ther Nucl Med 124:577–582
Rosenthal DI, Chandler HL, Azizi F, Schneider PB (1977) Uptake of bone imaging agents by diffuse pulmonary metastatic calcification. AJR Am J Roentgenol 129:871–874
Rosenthall L (1978) 99MTc-metyhlene diphosphonate concentration in soft tissue malignant fibrous histiocytoma. Clin Nucl Med 3:58–61
Sarreck R, Sham R, Alexander LL, Cortez EP (1979) Increased 99mTc-pyrophosphate uptake with radiation pneumonitis. Clin Nucl Med 4:103–104
Schmitt GH, Holmes RA, Isitman AT, Hensley GT, Lewis JD (1974) A proposed mechanism for 99mTc-labeled polyphosphate and diphosphonate uptake by human breast tissue. Radiology 112:733–735
Seid K, Lin D, Flowers WMJ (1981) Intense myocardial uptake of Tc-99m-MDP in a case of hypercalcemia. Clin Nucl Med 6:565–567
Serafini AN, Raskin MM, Zand LC, Watson DD (1974) Radionuclide breast scanning in carcinoma of the breast. J Nucl Med 15:1149–1152
Shen AC, Jennings RB (1972a) Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 67:417–440
Shen AC, Jennings RB (1972b) Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol 67:441–452
Sherkow L, Ryo UY, Fabich D, Patel GC, Pinsky SM (1984) Visualization of the liver, gallbladder, and intestine on bone scintigraphy. Clin Nucl Med 9:440–443
Siddiqui AR, Stokka CL (1980) Uptake of Tc-99m-methylene diphosphonate in a surgical scar. Clin Nucl Med 5:274
Silberstein EB, Bove KE (1979) Visualization of alcohol-induced rhabdomyolysis: a correlative radiotracer, histochemical, and electron-microscopic study. J Nucl Med 20:127–129
Silberstein EB, Francis MD, Tofe AJ, Slough CL (1975) Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues. J Nucl Med 16:58–61
Silberstein EB, DeLong S, Cline J (1984) Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication. J Nucl Med 25:1300–1303
Singh BN, Ryerson TW, Kesala BA, Mehta SP (1977) 99mTc-Diphosphonate uptake in renal cell carcinoma. Clin Nucl Med 2:95–99
Spencer RP, Datu JA (1980) Bilateral lower limb uptake of bone scanning agents. Semin Nucl Med 10:314–316
Steinfeld JR, Thorne NA, Kennedy TF (1977) Positive 99mTc-pyrophosphate bone scan in polymyositis. Radiology 122:168
Stokkel MP, Valdes Olmos RA, Hoefnagel CA (1994) Unexpected pulmonary uptake of [99mTc]MDP in a patient with bronchopneumonia. Semin Nucl Med 24:246–247
Stone CK, Sisson JC (1985) What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance. J Nucl Med 26:250–253
Straub WH, Slasky BS (1982) Accumulation of bone scanning agent in a communicating renal cortical cyst. Clin Nucl Med 7:378
Sty JR, Garrett R (1978) Abnormal myocardial image with 99mTc-pyrophosphate in a child on chemotherapy. Clin Nucl Med 3:65–66
Sty JR, Starshak RJ (1978) Scintigraphy in Wolman’s disease. Clin Nucl Med 3:397
Sty JR, Starshak RJ (1982) Abnormal Tc-99m MDP renal images associated with myoglobinuria. Clin Nucl Med 7:476
Sty JR, Chusid MJ, Babbitt DP (1979a) Scintigraphic findings of uncommon focal manifestations of Haemophilus influenzae septicemia. Clin Nucl Med 4:455–460
Sty JR, Babbitt DP, Kun L (1979b) Atlas of 99mTc-methylene diphosphonate renal images in pediatric oncology. Clin Nucl Med 4:122–127
Sty JR, Babbitt DP, Sheth K (1980) Abnormal Tc-99m-methylene diphosphonate accumulation in the kidneys of children with sickle cell disease. Clin Nucl Med 5:445–447
Sty JR, Starshak RJ, Hubbard A (1982) Accumulation of Tc-99m MDP in the spleen of a battered child. Clin Nucl Med 7:292
Suzuki Y, Hisada K, Takeda M (1974) Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. Radiology 111:663–664
Sy WM, Patel D, Faunce H (1975) Significance of absent or faint kidney sign on bone scan. J Nucl Med 16:454–456
Tanaka T, Rossier AB, Hussey RW, Ahnberg DS, Treves S (1977) Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology 123:217–221
Trackler RT, Chinn RY (1982) Amphotericin B therapy: a cause of increased renal uptake of Tc-99m MDP. Clin Nucl Med 7:293
Tsai SC, Kao CH, Lin WY, Wang SJ (1999) Intestinal accumulation of Tc 99m MDP on bone scan. Semin Nucl Med 29:80–81
Valdez VA, Jacobstein JG (1980) Visualization of a malignant pericardial effusion with Tc-99m-EHDP. Clin Nucl Med 5:210–212
VanAntwerp JD, O’Mara RE, Pitt MJ, Walsh S (1975) Technetium-99m-diphosphonate accumulation in amyloid. J Nucl Med 16:238–240
Vanhecke W, Merckx E, De Roo M, Mortelmans L (1989) Soft tissue uptake on Tc-99m MDP bone scan after cardioversion. Clin Nucl Med 14:923
Vieras F (1977) Radiation induced skeletal and soft tissue bone scan changes. Clin Nucl Med 2:93–94
Vieras F, Boyd CM (1975) Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J Nucl Med 16:1109–1114
Wahner HW, Dewanjee MK (1981) Drug-induced modulation of Tc-99m pyrophosphate tissue distribution: what is involved? J Nucl Med 22:555–559
Wilkinson RH Jr, Gaede JT (1979) Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma. J Nucl Med 20:303–305
Williamson BR, Teates CD, Bray ST, Lees RF, Croft BY (1979) Renal excretion simulating bone disease on bone scans – a technique for solving this problem. Clin Nucl Med 4:200–201
Wilson MA, Pollack MJ (1981) Gastric visualization and image quality in radionuclide bone scanning: concise communication. J Nucl Med 22:518–521
Winter PF (1976) Letter: splenic accumulation of 99mTc-diphosphonate. J Nucl Med 17:850
Zimmer AM, Isitman AT, Holmes RA (1975) Enzymatic inhibition of diphosphonate: a proposed mechanism of tissue uptake. J Nucl Med 16:352–356
Zuckier LS, Freeman LM (2010) Nonosseous, nonurologic uptake on bone scintigraphy: atlas and analysis. Semin Nucl Med 40:242–256
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hassan, F.U., Nathan, M., Gnanasegaran, G., Fogelman, I. (2012). Soft Tissue Uptake in Radionuclide Bone Scintigraphy. In: Fogelman, I., Gnanasegaran, G., van der Wall, H. (eds) Radionuclide and Hybrid Bone Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02400-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-02400-9_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02399-6
Online ISBN: 978-3-642-02400-9
eBook Packages: MedicineMedicine (R0)